Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-19
- Last Posted Date
- 2009-09-11
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 28
- Registration Number
- NCT00847405
- Locations
- 🇨🇦
Biovail Contract Research, Toronto, Ontario, Canada
Amlodipine 10 mg Tablets Under Fed Conditions
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 28
- Registration Number
- NCT00841815
- Locations
- 🇨🇦
Biovail Contract Research, Toronto, Ontario, Canada
Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 50
- Registration Number
- NCT00841698
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00841659
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Amlodipine 10 mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 28
- Registration Number
- NCT00841542
- Locations
- 🇨🇦
Biovail Contract Research, Toronto, Ontario, Canada
600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 48
- Registration Number
- NCT00840099
- Locations
- 🇨🇦
Pharma Medica Research Inc., Toronto, Ontario, Canada
Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 66
- Registration Number
- NCT00840411
- Locations
- 🇺🇸
Gateway Medical Research, Saint Charles, Missouri, United States
Cefprozil 500 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 38
- Registration Number
- NCT00840281
- Locations
- 🇺🇸
Gateway Medical Research, Saint Charles, Missouri, United States
Mesalamine 4 gm/60 mL Rectal Enema
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 72
- Registration Number
- NCT00840203
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Pittsburgh, Pennsylvania, United States
Cefprozil 500 mg Tablets Under Fed Conditions
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 39
- Registration Number
- NCT00840866
- Locations
- 🇺🇸
Gateway Medical Research, Saint Charles, Missouri, United States
© Copyright 2024. All Rights Reserved by MedPath